Researchers at the University of Gothenburg, Sweden, have discovered that changes in the structure of sugar molecules, known as glycans, in cancer cells could be key to identifying various types of cancer.
This groundbreaking study suggests that these molecular alterations could lead to the development of a simple blood or saliva test for early cancer detection. With cancer cases projected to rise to 28.4 million by 2040, early detection is crucial for improving treatment outcomes.
Glycans, complex sugar molecules attached to proteins and fats, undergo significant changes in cancer cells, affecting their function. These changes, influenced by factors such as mutations and inflammation within tumors, make glycans a promising target for cancer diagnosis.
The study utilized advanced AI techniques to analyze glycans’ substructures in tumor and healthy tissues from around 220 individuals, identifying distinctive patterns associated with various cancers like gastric, skin, liver, prostate, colorectal, and ovarian.
The potential for a non-invasive diagnostic tool such as a blood or saliva test is immense, offering a way to monitor cancer progression and recurrence with minimal discomfort compared to traditional biopsies.
The research team aims to further validate their findings by collecting saliva samples from lung cancer patients and developing specific tests for the identified cancer markers. This could lead to rapid, reliable, and cost-effective cancer diagnostics within the next four to five years.
This innovative approach, combining the detailed study of glycans with AI, opens new avenues in cancer research, holding promise for earlier and more accurate cancer detection.
The implications of such a test could be transformative, potentially ushering in a new era of cancer diagnosis and management.
Source: Medical News Today
Image by Juraj Varga from Pixabay
